Risk stratification of non-alcoholic fatty liver disease across body mass index in a community basis

J Formos Med Assoc. 2020 Jan;119(1 Pt 1):89-96. doi: 10.1016/j.jfma.2019.03.014. Epub 2019 Apr 2.

Abstract

Background: The features and risk analysis of non-alcoholic fatty liver disease (NAFLD) in a community-based setting remain elusive. The predictors between obese and lean subjects need further clarification. We aimed to assess the characteristics of NAFLD during a community screening. The associated metabolic abnormalities and cardiovascular risk assessment were also analyzed.

Methods: A total of 2483 subjects receiving multi-purpose health screening at 10 primary care centers were recruited. They received clinical assessment, including demographic data, laboratory examination, and abdominal sonography.

Results: The prevalence of NAFLD and metabolic syndrome were 44.5%, and 15.8%, respectively. Among those NAFLD subjects, 1212 (48.8%) subjects were obese (BMI≥ 24 kg/m2). There was an increasing trend of NAFLD according to age, ranging from 25.8% of those aged <30 years to 54.4% of those aged 50-70 years (P for trend< 0.0001). High insulin resistance (IR) was the significant predictive factor for NAFLD in both obese (odds ratio [OR] = 3.85, 95% confidence interval [CI] = 1.87-8.36, P = 0.0002) and lean subjects (OR = 2.52, 95% CI = 1.13-5.54, p = 0.02). The prevalence of high Framingham Risk Score (≥7.5%) was 56.7% (211/372) among the male subjects, which was significantly higher than that (26%, 191/734) of the females (P < 0.001). There was a significant increase of high Framingham Risk Score according to BMI, ranging from 23.1% of BMI<24 kg/m2 to 45% of BMI>27 kg/m2 (P for trend< 0.0001).

Conclusion: IR is predictive of NAFLD irrespective of BMI. The cardiovascular risk may exist in lean NAFLD subjects.

Keywords: Community screening; Insulin resistance; Metabolic syndrome; Non-alcoholic fatty liver disease; Risk assessment.

Publication types

  • Multicenter Study

MeSH terms

  • Adult
  • Aged
  • Body Mass Index*
  • Female
  • Humans
  • Logistic Models
  • Male
  • Metabolic Syndrome / epidemiology*
  • Middle Aged
  • Multivariate Analysis
  • Non-alcoholic Fatty Liver Disease / epidemiology*
  • Obesity / epidemiology*
  • Prevalence
  • Risk Assessment
  • Risk Factors
  • Taiwan / epidemiology